CC
TMO icon

Callan Capital’s Thermo Fisher Scientific TMO Stock Holding History

Callan Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$292K Sell
586
-187
-24% -$101K 0.02% 291
2024
Q4 		$402K Buy
773
+20
+3% +$11K 0.03% 214
2024
Q3 		$466K Buy
753
+175
+30% +$104K 0.03% 185
2024
Q2 		$320K Buy
578
+84
+17% +$48.1K 0.03% 226
2024
Q1 		$287K Buy
+494
New +$277K 0.03% 213
2022
Q2 		– Sell
-380
Closed -$224K – 127
2022
Q1 		$224K Buy
380
+22
+6% +$12.6K 0.03% 115
2021
Q4 		$239K Buy
+358
New +$224K 0.03% 122

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Callan Capital's TMO Position: Q1 2025 in Review

Callan Capital reduced its Thermo Fisher Scientific (TMO) stake by 24% in Q1 2025, selling an estimated $101K and leaving 586 shares worth $292K. The position accounts for 0.02% of the portfolio, ranked #291.

Callan Capital first reported a position in TMO in Q4 2021 and has held it in 7 quarters since. The position peaked at $466K in Q3 2024. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Callan Capital held 586 shares of Thermo Fisher Scientific worth $292K as of Q1 2025.
  • Callan Capital sold 187 Thermo Fisher Scientific shares in Q1 2025, an estimated $101K.
  • Thermo Fisher Scientific made up 0.02% of Callan Capital's portfolio in Q1 2025, its #291 holding.
  • Callan Capital first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 7 quarters since.
  • Callan Capital's Thermo Fisher Scientific position peaked at $466K in Q3 2024.
  • 2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.